Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group. - Wikidata - wikimedia - TriplyDB

Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group.

Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group.

http://www.wikidata.org/entity/Q33166364

about

The Semantics of Priapism and the First Sign of Chronic Myeloid Leukemia.

P2860

Q38375186-7DBADA90-CFEE-4746-953C-EEA6E734F27F

P2860

Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group.

http://www.wikidata.org/entity/Q33166364

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@ast

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@en

type

label

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@ast

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@en

prefLabel

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@ast

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@en

P1433

Q33166364-4E797A81-7DE5-43E0-9AAF-70B6EE27DEB3

P1476

Q33166364-866F846D-798A-4BAD-A3F5-F449D3A0149C

P2093

Q33166364-15196B5E-B903-44F3-B845-BCEDAC1A9B50

Q33166364-1F911DBE-56E8-4658-8272-32F2CA258A69

Q33166364-1FDDA494-68BF-4ED8-B729-9C25F7E2F756

Q33166364-2537D331-9488-44BB-8F42-089D5B47491F

Q33166364-41CE5902-137D-4242-94D6-B2A3CCDB78F0

Q33166364-70BDEBC0-2D22-4498-9F5C-74AD45BA7011

Q33166364-8DED1F9F-6DEC-420C-A8D5-55D4B5A5D862

Q33166364-9BEA2182-D5FD-4CF0-BCE9-9CFC46A71D67

Q33166364-9CFF4479-9A97-4CF0-8A0E-A643C0E42B67

Q33166364-A1338F6C-55F6-4F74-B878-110646AE36D5

P2860

Q33166364-04F03210-987E-4253-8212-7F7EDB22410A

Q33166364-18257E98-DE3D-48F5-93CF-C9E355BC3F43

Q33166364-18BC4BD4-AA5B-46A4-9186-B42A31851FC2

Q33166364-18D315E9-2785-4F51-A238-D5B3A1C2BD92

Q33166364-2B4DDB85-C0E2-4BB2-A950-54F69F0B76A0

Q33166364-3C48645A-51C6-46D6-9106-814781AB946A

Q33166364-5ED4E02B-BE15-460D-8EEE-BCEB0F6E0FE6

Q33166364-619AFA18-0FFE-4895-836C-371E8F08CF25

Q33166364-66776059-E236-4EBD-A920-433AE6595F69

Q33166364-6DC58A2C-4695-4A35-9EA7-B906F5011AE1

P304

Q33166364-ED2B24D7-F067-411B-8E88-780103142CCB

P31

Q33166364-58D3DCC4-22D2-41A2-85F1-3D4CC0813681

P356

Q33166364-ED0D575F-50AF-4FFC-B4E0-8CC876D645A7

P433

Q33166364-5C0E8141-25E7-4065-B120-0D0F22F03DD3

P478

Q33166364-D939809D-D68D-4A43-BF77-B1663A6893E0

P577

Q33166364-CBBBBA7C-2092-49DC-B92F-1715D07996E0

P698

Q33166364-BBECDE25-1167-4588-BF2C-81CB8763CCD2

P921

Q33166364-58EBCE71-8BF6-44C4-972F-E072907E3922

Q33166364-EDBCD546-21A8-4146-9E57-46A4492C5F98

P356

P1433

Pediatric Blood & Cancer

P1476

Leukostasis in Children and Ad ...... Leukemia/Lymphoma Study Group.

@en

P2093

Akihiko Tanizawa

http://www.w3.org/2001/XMLSchema#string

Akihiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Akiko Moriya Saito

http://www.w3.org/2001/XMLSchema#string

Chikako Tono

http://www.w3.org/2001/XMLSchema#string

Eiichi Ishii

http://www.w3.org/2001/XMLSchema#string

Haruko Shima

http://www.w3.org/2001/XMLSchema#string

Hideki Muramatsu

http://www.w3.org/2001/XMLSchema#string

Hidemitsu Kurosawa

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Shimada

http://www.w3.org/2001/XMLSchema#string

Keizo Horibe

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.

Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase.

How I manage priapism in chronic myeloid leukaemia patients.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

American Urological Association guideline on the management of priapism.

Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period.

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

Ophthalmic manifestations of acute leukaemias: the ophthalmologist's role.

How I treat childhood CML.

Hearing loss in chronic myeloid leukemia.

P304

406-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.25803

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26485422

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia